Tyra Biosciences (TYRA) Prepaid Assets (2020 - 2026)
Tyra Biosciences (TYRA) reported Prepaid Assets of $11.1 million for Q1 2026, up 98.24% on a YoY basis from $5.6 million in Q1 2025, and up 18.0% quarter-over-quarter from $9.4 million in Q4 2025.
Tyra Biosciences (TYRA) Prepaid Assets (2020 - 2026) Analysis & Trends
Tyra Biosciences has reported Prepaid Assets for 7 years, with the latest figure at $11.1 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 98.24% year-over-year to $11.1 million; the trailing twelve-month figure through Mar 2026 stood at $11.1 million (up 98.24% YoY), and the FY2025 full-year result was $9.4 million, up 56.87% from the prior year.
- Prepaid Assets for Q1 2026 stood at $11.1 million, up from $9.4 million in the prior quarter.
- The five-year high for Prepaid Assets was $11.1 million in Q1 2026, with the low at $1.5 million in Q1 2022.
- Historically, Prepaid Assets has averaged $6.3 million across 5 years, with a median of $6.0 million in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 528.32% — and 2024, when it sank 42.66%.
- Tyra Biosciences' Prepaid Assets stood at $6.1 million in 2022, then soared by 35.01% to $8.2 million in 2023, then declined by 26.58% to $6.0 million in 2024, then jumped by 56.87% to $9.4 million in 2025, then climbed by 18.0% to $11.1 million in 2026.
- The last three Prepaid Assets figures came in at $11.1 million (Q1 2026), $9.4 million (Q4 2025), and $6.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Tyra Biosciences | 1.67 Bn | 1.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.15 Mn |
| Dec 31, 2025 | 9.45 Mn |
| Sep 30, 2025 | 6.29 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 5.62 Mn |
| Dec 31, 2024 | 6.02 Mn |
| Sep 30, 2024 | 5.48 Mn |
| Jun 30, 2024 | 4.78 Mn |
| Mar 31, 2024 | 8.32 Mn |
| Dec 31, 2023 | 8.20 Mn |
| Sep 30, 2023 | 8.98 Mn |
| Jun 30, 2023 | 8.33 Mn |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 6.08 Mn |
| Sep 30, 2022 | 4.26 Mn |
| Jun 30, 2022 | 2.19 Mn |
| Mar 31, 2022 | 1.53 Mn |
| Dec 31, 2021 | 1.88 Mn |
| Sep 30, 2021 | 678,000.00 |
| Dec 31, 2020 | 57,000.00 |